Artificial intelligence is rapidly becoming part of clinical research. From clinical data management and medical writing to pharmacovigilance, patient recruitment, protocol development, and regulatory submissions, AI can significantly accelerate activities that traditionally required substantial human effort.
But there
is a hidden cost that the industry cannot afford to overlook: AI
hallucinations.
An AI
hallucination occurs when an AI system generates information that appears
credible but is inaccurate, unsupported, or completely fabricated. In clinical
research, where decisions depend on data accuracy and traceability, even a
seemingly minor hallucination can have consequences far beyond correcting a
sentence.
The Cost
of Incorrect Information
Consider
an AI system generating a clinical summary that incorrectly states that a
patient experienced a serious adverse event, or fails to recognize an important
safety signal. The immediate problem may appear to be a data-quality issue.
However, the consequences can cascade through the clinical development process.
An
incorrect output may trigger unnecessary medical review, additional data
queries, reconciliation activities, or investigation. Conversely, failure to
identify a genuine issue could potentially affect patient safety.
The cost
is therefore not simply the cost of correcting an erroneous AI output. It
includes the downstream cost of decisions made because of that output.
The
Productivity Paradox
AI is
often introduced to reduce manual workload. However, uncontrolled
hallucinations can create a productivity paradox.
If every
AI-generated output requires extensive manual verification, the organization
may simply replace one form of manual work with another. Medical reviewers,
data managers, pharmacovigilance professionals, and regulatory specialists may
spend significant time checking AI outputs rather than performing higher-value
activities.
The value
of automation therefore depends not only on how much work AI can perform, but
also on how much verification that work requires.
Regulatory
and Compliance Costs
Clinical
research operates within a highly regulated environment. Documentation must be
accurate, attributable, traceable, and reproducible.
An
AI-generated statement that cannot be traced to an underlying source creates a
significant governance problem. Incorrect information appearing in a clinical
report, safety document, submission package, or other regulated record can
potentially lead to additional review, remediation, investigation, and
regulatory scrutiny.
Organizations
therefore need clear controls around AI-generated content, including source
verification, audit trails, version control, human review, and appropriate
documentation.
The
Patient-Safety Dimension
The most
important cost cannot always be measured in dollars.
An
inaccurate AI-generated interpretation of clinical data could potentially
contribute to an incorrect assessment of a patient's safety or treatment
response. This makes hallucination management fundamentally different from
ordinary enterprise AI applications.
In
clinical research, accuracy is not merely a quality metric—it can be a
patient-safety requirement.
Building a
Hallucination-Resistant Ecosystem
The answer
is not to avoid AI. Instead, organizations need to build systems in which AI
operates within appropriate boundaries.
Retrieval-augmented
generation, structured clinical datasets, source-linked outputs, automated
validation rules, confidence indicators, human-in-the-loop review, and
continuous performance monitoring can substantially improve reliability.
AI should
also be assigned tasks according to risk. Generating a first draft of a
non-critical document is very different from interpreting a potential safety
signal.
From AI
Adoption to AI Governance
The real
question for clinical research organizations is therefore not "How much
can AI save?" but "What happens when AI is wrong?"
A
meaningful AI business case should consider both productivity gains and the
potential cost of errors, verification, remediation, compliance, and risk
management.
The future
of AI in clinical research will depend on trust. And trust will not come from
assuming that AI is accurate. It will come from designing systems that know
where AI can help, where it needs verification, and where humans must remain
firmly in control.
In
clinical research, the cheapest hallucination is the one that is prevented—or
detected before it influences a decision.
